Welcome to LookChem.com Sign In|Join Free

CAS

  • or
2-Benzyl-4-bromoisoindoline is a chemical compound that belongs to the class of organic compounds known as benzylisoindolines. It features a benzyl group attached to an isoindoline moiety, which may suggest potential applications in various fields due to its structural characteristics. Although specific details about its physical properties or uses are not extensively documented, its chemical composition, including the presence of a bromine atom, hints at possible roles in organic synthesis, pharmaceuticals, or materials science where halogens are valued for their reactivity. Safe handling and disposal are crucial due to the potential for flammability, toxicity, or environmental impact.

923590-78-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 923590-78-7 Structure
  • Basic information

    1. Product Name: 2-Benzyl-4-bromoisoindoline
    2. Synonyms: 2-Benzyl-4-bromoisoindoline;2-benzyl-4-broMo-2,3-dihydro-1H-isoindole;1H-Isoindole, 4-broMo-2,3-dihydro-2-(phenylMethyl)-
    3. CAS NO:923590-78-7
    4. Molecular Formula: C15H14BrN
    5. Molecular Weight: 288.187
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 923590-78-7.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 354 °C at 760 mmHg
    3. Flash Point: 167.9 °C
    4. Appearance: /
    5. Density: 1.412 g/cm3
    6. Refractive Index: N/A
    7. Storage Temp.: Sealed in dry,Room Temperature
    8. Solubility: N/A
    9. CAS DataBase Reference: 2-Benzyl-4-bromoisoindoline(CAS DataBase Reference)
    10. NIST Chemistry Reference: 2-Benzyl-4-bromoisoindoline(923590-78-7)
    11. EPA Substance Registry System: 2-Benzyl-4-bromoisoindoline(923590-78-7)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 923590-78-7(Hazardous Substances Data)

923590-78-7 Usage

Uses

Used in Organic Synthesis:
2-Benzyl-4-bromoisoindoline is used as a synthetic intermediate for the preparation of various complex organic molecules. Its bromine atom can be a key feature in reactions such as cross-coupling, which is widely used in the synthesis of pharmaceuticals and other specialty chemicals.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2-Benzyl-4-bromoisoindoline is used as a building block for the development of new drugs. Its unique structure and reactivity may contribute to the creation of novel therapeutic agents, particularly in the area of medicinal chemistry where the introduction of halogens can influence the pharmacokinetic and pharmacodynamic properties of drug candidates.
Used in Materials Science:
2-Benzyl-4-bromoisoindoline is used as a component in the development of advanced materials. Its chemical structure may be incorporated into the design of new materials with specific properties, such as improved thermal stability, electrical conductivity, or mechanical strength, which are essential in various applications across industries.

Check Digit Verification of cas no

The CAS Registry Mumber 923590-78-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,3,5,9 and 0 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 923590-78:
(8*9)+(7*2)+(6*3)+(5*5)+(4*9)+(3*0)+(2*7)+(1*8)=187
187 % 10 = 7
So 923590-78-7 is a valid CAS Registry Number.

923590-78-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Benzyl-4-bromoisoindoline

1.2 Other means of identification

Product number -
Other names 2-benzyl-4-bromo-1,3-dihydroisoindole

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:923590-78-7 SDS

923590-78-7Relevant articles and documents

THERAPEUTIC COMPOUNDS

-

Paragraph 0137; 0138, (2018/07/06)

no abstract published

ARYL LINKED IMIDAZOLE AND TRIAZOLE DERIVATIVES AND METHODS OF USE THEREOF FOR IMPROVING THE PHARMACOKINETICS OF A DRUG

-

, (2015/06/03)

The present invention relates to aryl linked imidazole and triazole derivatives, compositions comprising said compounds, alone or in combination with other drugs, and methods of using the compounds for improving the pharmacokinetics of a drug. The compounds of the invention are useful in human and veterinary medicine for inhbiting CYP3A4 and for improving the pharmacokinetics of a therapeutic compound that is metabolized by CYP3A4.

ARYL LINKED IMIDAZOLE AND TRIAZOLE DERIVATIVES AND METHODS OF USE THEREOF FOR IMPROVING THE PHARMACOKINETICS OF A DRUG

-

, (2015/06/03)

The present invention relates to aryl linked imidazole and triazole derivatives, compositions comprising said compounds, alone or in combination with other drugs, and methods of using the compounds for improving the pharmacokinetics of a drug. The compounds of the invention are useful in human and veterinary medicine for inhbiting CYP3A4 and for improving the pharmacokinetics of a therapeutic compound that is metabolized by CYP3A4.

HCV NS3 PROTEASE INHIBITORS

-

, (2012/04/10)

The present invention relates to macro-cyclic compounds of formula I that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections

Discovery of vaniprevir (MK-7009), a macrocyclic hepatitis C virus NS3/4a protease inhibitor

McCauley, John A.,McIntyre, Charles J.,Rudd, Michael T.,Nguyen, Kevin T.,Romano, Joseph J.,Butcher, John W.,Gilbert, Kevin F.,Bush, Kimberly J.,Holloway, M. Katharine,Swestock, John,Wan, Bang-Lin,Carroll, Steven S.,Dimuzio, Julian M.,Graham, Donald J.,Ludmerer, Steven W.,Mao, Shi-Shan,Stahlhut, Mark W.,Fandozzi, Christine M.,Trainor, Nicole,Olsen, David B.,Vacca, Joseph P.,Liverton, Nigel J.

experimental part, p. 2443 - 2463 (2010/09/03)

A new class of HCV NS3/4a protease inhibitors which contain a P2 to P4 macrocyclic constraint was designed using a molecular-modeling derived strategy. Exploration of the P2 heterocyclic region, the P2 to P4 linker, and the P1 side chain of this class of

Macrocyclic Compounds as Antiviral Agents

-

, (2009/12/27)

The present invention relates to macrocyclic compounds of formula (I): wherein W, n, m, R1, R2, R3, R4, R5, Ra, M, Z and ring B are defined herein, and pharmaceutically acceptable salts the

HCV NS3 PROTEASE INHIBITORS

-

Page/Page column 33-34, (2008/12/05)

The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use treating or preventing HCV infections.

HCV NS3 PROTEASE INHIBITORS

-

Page/Page column 46, (2008/12/05)

The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections.

HCV NS3 protease inhibitors

-

Page/Page column 62, (2008/06/13)

The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 923590-78-7